AbbVie Inc.Long
$ABBV long
Mis à jour
ABBV was trading lower on friday after the the FDA pushed back the review period for the company's supplemental marketing application for upadacitinib in active psoriatic arthritis. Despite the big drop, it fell right to key support (right at the bottom of a range) making a good entry here in terms of RR, having a tight stop and aiming for the top of range (gap fill). For options, look for leaps.Transaction en cours
Added a swing position at open, looks great so far.Trade fermée: cible de profit atteinte
trimmed most of my position here and only have runner left. great profits!
Autopsy of my trades.
Admin of SimbaStocks.
Not a registered financial advisor, all related content are my opinions and solely my opinions.
Admin of SimbaStocks.
Not a registered financial advisor, all related content are my opinions and solely my opinions.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.